Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Cyclacel Pharmaceuticals ( NASDAQ:CYCC )

2 weeks ago

A downtrend has been apparent in Cyclacel Pharmaceuticals, Inc. CYCC lately. While the stock has lost 13.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session.

Ticker	Sentiment	Impact
CYCC	Bullish	39 %